Meeting NewsPerspective

Greater operator, hospital mitral valve surgery volume tied to reduced mortality, more repair

September 28, 2019
SAN FRANCISCO — Higher operator and hospital volume conferred better results for 30-day operative mortality, successful repair of primary…

Meeting NewsPerspective

EXCEL: PCI ‘acceptable revascularization modality’ for left main CAD at 5 years

September 28, 2019
SAN FRANCISCO — Final 5-year data from the EXCEL trial demonstrate similar rates of death, stroke or MI with PCI or CABG for treatment of…

Meeting NewsPerspective

PARTNER 2A: TAVR remains similar to surgery for 5-year outcomes in intermediate-risk population

September 28, 2019
SAN FRANCISCO — At 5 years, transcatheter aortic valve replacement with the Sapien XT device was similar to surgical AVR for death and…

Meeting NewsPerspective

Subclinical leaflet thrombosis not tied to serious clinical events: PARTNER 3 CT substudy

September 27, 2019
SAN FRANCISCO — In a CT substudy of the PARTNER 3 trial of low surgical risk patients who underwent transcatheter or surgical aortic valve…

Highlights from ESC Congress: DAPA-HF, new guidelines, intervention updates and more

September 22, 2019
Whether you attended the European Society of Cardiology Congress in person or followed from afar, Cardiology Today and Healio have you covered. Our…

FDA News

Investigational new drug application accepted for treatment to prevent AKI after cardiac surgery

September 19, 2019
The FDA has accepted an investigational new drug application to evaluate the efficacy of Elysium Health’s cellular health supplement in…

Feature

Q&A: Network aims to boost underrepresented populations in cardiac surgery trials

September 19, 2019
The Keck School of Medicine of the University of Southern California received a $4.5 million grant from the NIH and NHLBI to fund efforts in…

Top news of August: Sex-specific CVD risk factors, prescription fish oil and more

September 7, 2019
Healio and Cardiology Today compiled a list of the most-viewed cardiology posts in August. This month, our readers were interested in barriers for…

Meeting News

Metabolic surgery yields reduced CV events in obesity, type 2 diabetes

September 6, 2019
PARIS — Metabolic surgery for patients with obesity and type 2 diabetes was linked to lower incidence of major adverse CV events compared with…

Meeting News

SCAI SHOCK to focus on diagnosis, treatment, systems issues in cardiogenic shock

September 6, 2019
The second annual SCAI SHOCK meeting, organized by the Society for Cardiovascular Angiography and Interventions, aims to offer information to help…

Meeting News

Statins, antiplatelets, RAAS inhibitors tied to mortality benefit after CABG: SWEDEHEART

September 4, 2019
PARIS — New data from the SWEDEHEART registry presented at the European Society of Cardiology Congress show that use of statins, antiplatelet…

Meeting News

Untreated aortic stenosis confers poor survival regardless if moderate or severe

September 4, 2019
PARIS — Patients with aortic stenosis have poor survival rates if their condition is left untreated, regardless of whether their stenosis is…

Meeting NewsPerspective

SYNTAXES: No mortality difference at 10 years with PCI or CABG

September 3, 2019
PARIS — Ten-year follow-up data from the SYNTAXES trial highlight no significant difference in all-cause death among patients who underwent PCI…

Meeting NewsPerspective

Rivaroxaban monotherapy noninferior to combo therapy for AF, stable CAD

September 2, 2019
PARIS — In the AFIRE trial, rivaroxaban monotherapy was noninferior to rivaroxaban plus an antiplatelet agent with respect to CV events and…

Meeting News

POPular AGE: Clopidogrel remains an option for elderly with ACS

August 31, 2019
PARIS — New data from the POPular AGE study support the use of clopidogrel over ticagrelor and prasugrel, based on significant reduction in…

In the Journals

Early anticoagulation may reduce stroke risk after surgical AVR

August 28, 2019
Early anticoagulation after bioprosthetic aortic valve replacement was associated with short-term reduced risk for stroke in patients who had…

In the Journals

ODYSSEY OUTCOMES: Alirocumab reduces CV event risk for polyvascular disease, CABG

August 26, 2019
Alirocumab reduced the risk for major adverse CV events and death in patients with recent ACS and polyvascular disease and in those with CABG after…

In the Journals

Viable myocardium not linked to long-term CABG benefit for ischemic cardiomyopathy

August 21, 2019
Myocardial viability was not linked to a long-term benefit from CABG in patients with ischemic cardiomyopathy, according to results from the STICH…

In the Journals

Cardiac rehab referral rates lacking after CICU discharge, especially for patients with HF

August 13, 2019
In a new study, nearly 63% of patients discharged from the cardiac ICU had an indication for cardiac rehabilitation, yet only 30% were referred upon…

In the Journals

Statin use promotes limb salvage, survival after PAD procedures

August 11, 2019
Among patients with peripheral artery disease who underwent a surgical or endovascular intervention, statin use after the procedure was associated…